Scott B. Willoughby
CIK 1877368 · SVP, CHIEF LEGAL OFFICER, SECY · last filed 2026-05-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
30
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | SVP, CHIEF LEGAL OFFICER, SECY | 663,760 | $0.18 | $117.9K | $0 | 29 | 2026-04-03 |
Recent Filings · Page 3 of 3
30 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-15 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −864 | -$933 | EDGAR |
| 2023-05-30 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −1,328 | -$1.8K | EDGAR |
| 2023-04-26 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −3,977 | -$6.6K | EDGAR |
| 2023-03-06 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Mixed | +37,622 | -$13.6K | EDGAR |
| 2022-08-16 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −864 | -$5.5K | EDGAR |
| 2022-05-03 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −140 | -$581 | EDGAR |
| 2022-04-26 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −3,976 | -$18.7K | EDGAR |
| 2022-03-01 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Mixed | +39,434 | -$9.2K | EDGAR |
| 2021-11-03 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Tax (F) | −140 | -$1.1K | EDGAR |
| 2021-08-17 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +7,500 | $0 | EDGAR |
Showing 21–30 of 30
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.